Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

AstraZeneca Pharma India Ltd

NSE: ASTRAZEN · BSE: 506820 · Pharmaceuticals & Biotechnology · 42 announcements

Share price
₹5,927.00
Market cap
₹14,818 Cr
Revenue (annual)
₹2,276 Cr
Net profit (annual)
₹187.5 Cr
P/E (TTM)
87.4×Sector 47.4×
Promoter holding
75.00%+0.00% QoQ
FII holding
2.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

23:32 IST BSE
Annual General Meeting

AstraZeneca Pharma India Annual General Meeting

AstraZeneca Pharma India held its 47th Annual General Meeting on August 10, 2026, where shareholders approved financial statements, dividend declaration, and key director and auditor appointments.

18:53 IST BSE
Annual General Meeting

AstraZeneca Pharma India Annual General Meeting

AstraZeneca Pharma India will hold its 47th Annual General Meeting on August 10, 2026, via video conferencing to transact ordinary and special business.

13:53 IST BSE
Annual General Meeting

AstraZeneca Pharma India Annual General Meeting

AstraZeneca Pharma India announced shareholders approved shifting its registered office to Maharashtra via postal ballot. The special resolution passed with a 99.99% majority vote.

17:23 IST BSE
Annual General Meeting

AstraZeneca Pharma India Annual General Meeting

AstraZeneca Pharma India Ltd has issued a postal ballot notice to shift its registered office from Karnataka to Maharashtra. The move aims to enhance administrative efficiency and strengthen the company's footprint in Mumbai. Shareholders can vote electronically from April 12 to May 11, 2026.